Intrinsic Capacity Screening in Apparently Healthy Adults

Abstract

Intrinsic capacity (IC) is a multidimensional construct reflecting the composite of all the physical and mental capacities that an individual can draw upon. As a fundamental concept in the World Health Organization’s framework for healthy aging, IC encompasses cognition, locomotion, vitality, sensory, and psychological domains. Proactive screening of IC in apparently healthy adults enables the early identification of subtle functional decline, offering opportunities for preventive interventions prior to the onset of clinically overt disease or disability. This review synthesizes current evidence regarding IC screening in healthy adults, addresses epidemiological trends, pathophysiological underpinnings, risk factors, and clinical features, and discusses diagnostic approaches, management strategies, recent advances, and guideline recommendations. The article underscores the clinical value of IC assessment in routine practice and highlights future directions in this rapidly evolving field.

Introduction

With the global demographic shift toward aging populations, there is increasing recognition of the need to optimize functional ability across the lifespan. Intrinsic capacity, as championed by the World Health Organization’s Decade of Healthy Ageing, provides a holistic approach to assessing and promoting health and function beyond the absence of disease. Unlike traditional disease-centric models, intrinsic capacity screening focuses on identifying early, subclinical decrements in function, particularly in individuals who may appear healthy during routine clinical encounters. The multidimensional assessment of IC allows clinicians to anticipate and mitigate the risk of future dependency, frailty, and adverse health outcomes. This article reviews the rationale, methodology, and clinical implications of IC screening in community-dwelling adults, supported by current literature and international guidelines.

Epidemiology / Disease Burden

The burden of age-related functional decline is substantial and rising worldwide. Epidemiological studies indicate that approximately 20–30% of adults over the age of 60 experience declines in at least one domain of intrinsic capacity, even in the absence of overt disease. Early declines in cognitive, locomotor, or sensory capacity can precede the development of frailty, sarcopenia, and disability by several years. Population-based data from longitudinal cohorts, such as the Longitudinal Aging Study Amsterdam and the Health and Retirement Study, have demonstrated that subtle impairments in IC are associated with increased risk of falls, hospitalizations, reduced quality of life, and premature mortality. Given the silent and progressive nature of IC decline, the true epidemiological burden is likely underestimated in apparently healthy adult populations.

Pathophysiology

Intrinsic capacity is influenced by a complex interplay of genetic, biological, environmental, and behavioral factors. At the cellular level, age-related mitochondrial dysfunction, oxidative stress, chronic low-grade inflammation (inflammaging), and impaired autophagy contribute to the gradual loss of organ reserve and multisystem resilience. Neuroendocrine alterations, including dysregulation of the hypothalamic-pituitary-adrenal axis, further undermine adaptive responses to stressors. These processes collectively impair muscle strength, cognitive function, sensory acuity, and psychological well-being, even before the emergence of clinical disease. The heterogeneity of IC trajectories underscores the importance of individualized assessment and intervention.

Risk Factors

Multiple risk factors have been identified for declines in intrinsic capacity among apparently healthy adults. Advancing age remains the most significant non-modifiable risk. Modifiable contributors include physical inactivity, poor nutrition, social isolation, polypharmacy, chronic stress, and exposure to environmental toxins. Comorbidities such as hypertension, diabetes, and obesity, even when subclinical, can accelerate IC decline through shared pathophysiological pathways. Genetic predisposition, low educational attainment, and socioeconomic disadvantage also play important roles, emphasizing the need for a comprehensive and personalized approach to risk stratification.

Clinical Features

In apparently healthy adults, early declines in intrinsic capacity may manifest subtly. Clinical features can include mild reductions in gait speed, muscle strength, memory, attention, hearing, or vision. Psychological symptoms such as low mood, decreased motivation, or sleep disturbances may also be present. These changes are often under-recognized unless actively sought through structured screening tools. Importantly, most individuals with early IC decline do not fulfill criteria for frailty or disability, highlighting the utility of proactive, multidimensional assessment in primary care and preventive settings.

Diagnosis

The diagnosis of impaired intrinsic capacity relies on comprehensive, domain-specific assessment. Validated tools include the WHO Integrated Care for Older People (ICOPE) screening tool, which evaluates cognition, mobility, nutrition, vision, hearing, and mood. Objective measures such as grip strength, gait speed, Mini-Mental State Examination (MMSE), and audiometric and visual testing may supplement self-reported assessments. Serial monitoring enables the detection of deviations from individual baselines, facilitating timely intervention. Integration into electronic health records and routine health check-ups can enhance the feasibility and uptake of IC screening in clinical practice.

Treatment & Management

Management of intrinsic capacity decline is inherently multidisciplinary and tailored to the domains affected. Interventions may include structured exercise programs, nutritional optimization, cognitive training, sensory aids, psychosocial support, and deprescribing of inappropriate medications. Early engagement in preventive strategies has demonstrated efficacy in delaying the progression to frailty and dependency. Care coordination with geriatricians, physiotherapists, nutritionists, and mental health professionals is vital. Empowering individuals through health literacy and self-management also forms a cornerstone of effective IC maintenance.

Recent Advances / Emerging Therapies

Recent advances in IC screening and management include digital health platforms, remote monitoring, and artificial intelligence-enabled risk stratification. Wearable devices now permit continuous assessment of physical activity and mobility. Digital cognitive assessments and telehealth consultations facilitate early detection and intervention, even in resource-limited settings. Multimodal interventions, combining physical, cognitive, and nutritional components, show promise in randomized controlled trials. Precision medicine approaches, leveraging genetic and biomarker data, may further refine IC risk prediction and individualized care in the near future.

Guideline Recommendations

The World Health Organization recommends routine assessment of intrinsic capacity as part of integrated care for older people, emphasizing early identification and intervention. National and international guidelines advocate for IC screening in primary care, especially in adults aged 50 and above. The ICOPE framework provides practical algorithms for risk stratification and management. Professional societies encourage interdisciplinary collaboration and the use of standardized, validated tools for IC assessment. Ongoing training and education of healthcare professionals are essential for successful implementation and scale-up.

Conclusion

Intrinsic capacity screening in apparently healthy adults represents a paradigm shift in preventive medicine, facilitating the early detection of functional decline and the implementation of personalized, multidimensional interventions. Emerging evidence supports the feasibility, clinical utility, and cost-effectiveness of IC assessment in routine practice. Continued research, technological innovation, and education are needed to optimize screening strategies and improve long-term health outcomes. By prioritizing intrinsic capacity, clinicians can empower individuals to maintain independence, quality of life, and healthy aging trajectories.